Immunic GAAP EPS of -$0.13 beats by $0.06
Source: SeekingAlpha
2025-11-13 06:35:18 ET
More on Immunic
- Immunic, Inc. (IMUX) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 - Slideshow
- Immunic, Inc. (IMUX) Presents at H.C. Wainwright 27th Annual Global Investment Conference - Slideshow
- Seeking Alpha’s Quant Rating on Immunic
- Historical earnings data for Immunic
- Financial information for Immunic
Read the full article on Seeking Alpha
For further details see:
Immunic GAAP EPS of -$0.13 beats by $0.06
Immunic Inc.
NASDAQ: IMUX
IMUX Trading
-2.12% G/L:
$1.385 Last:
2,943,476 Volume:
$1.50 Open:
IMUX Latest News
March 10, 2026 06:30:00 am
Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium
February 26, 2026 06:30:00 am
Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update
February 17, 2026 04:05:00 pm
Immunic Announces Closing of Oversubscribed Private Placement Financing
IMUX Stock Data
$99,716,036
88,288,987
2.21%
24
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
